Wednesday 26 Feb, 2025 06:17 PM
Site map | Locate Us | Login
   India Ratings affirms Mahindra Finance's long-term rating at 'AAA' with 'stable' outlook    Greenpanel Inds commissions new MDF plant at Andhra Pradesh    Waaree Energies secures 410 MW solar module supply order from ABREL EPC    Avantel bags purchase order worth Rs 2 cr from L&T    KP Green Engg inks MoU with Govt of MP for renewable energy projects    RailTel Corp bags multiple orders worth Rs 168 crore    Caplin Point Lab's subsidiary gets USFDA approval for new eye drop solution    Emcure Pharma's Maharashtra facility gets 2 USFDA observations    Spicejet reports turnaround PAT of Rs 25 cr in Q3 FY25    Tata Steel acquires equity stake worth Rs 10,727-cr in subsidiary, TSHP    Gland Pharma's Visakhapatnam facility gets 3 USFDA observations    Bhagyanagar India spurts on securing LoA from Govt of Maharashtra    CLN Energy rallies on bagging $5 million export order    Prism Johnson CEO Anil Suresh Kulkarni resigns    Adani Wilmar gets shareholders' nod to change firm name 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Emcure Pharma's Maharashtra facility gets 2 USFDA observations
26-Feb-25   13:23 Hrs IST

According to an exchange filing, the inspection was conducted at the company's Active Pharmaceutical Ingredient (API) manufacturing facility located at M.I.D.C., Kurkumbh, Maharashtra, from 19 February 2025 to 25 February 2025. At the conclusion of the inspection, the company received two observations in Form 483.

The company has stated that it is addressing the observations comprehensively and will respond to the USFDA within the required timeframe.

Pune-based Emcure Pharmaceuticals is a leading Indian pharma company engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products.

The company's consolidated net profit surged 35.5% to Rs 153.72 crore in Q3 FY25 as against Rs 113.45 crore posted in Q3 FY24. Revenue from operations jumped 17.7% YoY to Rs 1,962.63 crore in the quarter ended 31 December 2024.

The counter rose 0.96% to settle at Rs 988.80 on Tuesday, 25 February 2025. The stock market is closed today on account of Mahashivratri.

Powered by Capital Market - Live News
   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Investor Charter | Annual Return | Account Closure | RE-KYC | Disclaimer | Feed Back | Privacy Policy | Policies & Procedures | |Rights & Obligations-English| Rights & Obligations-தமிழ் | Anti Money Laundering Policy | E-Voting | CSR | Voluntary Freezing / Blocking Hit Count : 39155899
Useful Links : NSE | BSE | MCX | NSDL | CDSL | SEBI | RBI | ATTENTION INVESTOR| SMART ODR
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd